Markus Fries
Bis 2018, Regulatory Affairs, Baxter/Baxalta/Shire
Vienna, Österreich
Werdegang
Berufserfahrung von Markus Fries
Bis heute 6 Jahre und 6 Monate, seit 2018
Regulatory Affairs
Amomed Pharma GmbH
2011 - 2018
Regulatory Affairs
Baxter/Baxalta/Shire
In charge of directing and managing regulatory affairs activities for developing global strategies across product life cycles with a focus on CMC. Lead the preparation and filing of CMC sections of regulatory submissions and interactions with regulatory agencies. Develop global CMC regulatory strategy for investigational and marketed products. Manage regulatory assessment and guidance on product compliance topics.
2007 - 2011
Scientist, Team Leader
Baxter BioScience
Development of new therapies for the treatment of haemophilia.
2004 - 2007
Post-Doc
Queen Mary University of London
Elucidating mechanism and specificity of the virulence factors pectin methylesterase and pectate lyase. Supervision of PhD, masters and bachelor students as well as a lab technican.
Crystallographic studies of the thrombin-inhibitor heparin cofactor II
Ausbildung von Markus Fries
1998 - 2001
Biochemistry
University of Cambridge
Protein-protein interaction and catalysis in the pyruvate dehydrogenase multienzyme complex
1992 - 1997
Theoretical Medicine/Human Biology
University of Marburg
Diplom thesis: Expression, purification and crystallisation of the membrane protein dihydroorotate dehydrogenase Diplom subjects: Biochemistry, Molecular Biology, Immunology; Vordiplom subjects: Physics, Chemistry, Biology, Biochemistry, Physiology, Cell Biology, Anatomy and Histology